Retsina Meyer – Biography
Last update: April 17, 2026Executive profile
Retsina was Clinical Programs at Cohen Veterans Bioscience, and Vice President of Research and Development, Interim Chief Strategy Officer at VP of R&D, interim-CSONom de l’entrepriseStealth NewCo. Retsina Meyer joined Delix Therapeutics in 2021.
Retsina Meyer is currentlyHead of Corporate Strategy at Delix Therapeutics - View - Delix Therapeutics org chart
Create your alert
to follow the career of Retsina Meyer.
Education
Retsina Meyer has a Bachelor of Science in Biochemistry and Molecular Biophysics from University of Arizona and a Phd in Neuroscience from Massachusetts Institute of Technology.
They have also studied at University of Arizona :
Find more alumni from University of Arizona
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
More about Retsina Meyer
Selected links
Do you need to know more about Retsina Meyer? More results.
Participate
Social media
- Retsina Meyer on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Retsina Meyer
The colleagues of Retsina Meyer
Company Colleagues
- At Delix Therapeutics, Retsina Meyer has 11 colleagues including Mark Rus (CEO & Director), Nick Haft (Director)…
Industry Colleagues
- In the Biotechnology industry, Retsina Meyer has 35,757 colleagues in 2,406 companies located in 42 countries. 16,893 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Retsina Meyer.
Get in Touch
Here are a few tips for establishing great contacts.
